Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.
about
Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectivesImpact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.Comparative evaluation of triplet antiemetic schedule versus doublet antiemetic schedule in chemotherapy-induced emesis in head and neck cancer patients.Patterns of antiemetic prophylaxis for chemotherapy-induced nausea and vomiting in ChinaNEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK.Anticipatory nausea in animal models: a review of potential novel therapeutic treatments.The role of netupitant and palonosetron in chemotherapy-induced nausea and vomiting.Multifunctional nanoparticles: recent progress in cancer therapeutics.Rolapitant: first global approval.Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting.EA versus sham acupuncture and no acupuncture for the control of acute and delayed chemotherapy-induced nausea and vomiting: a pilot study.Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex interferes with anticipatory nausea in a rat model.Efficacy differences of electroacupuncture with single acupoint or matching acupoints for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial.Moxibustion for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis.Stability of azasetron-dexamethasone mixture for chemotherapy-induced nausea and vomiting administration.Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting.Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian survey.Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea.Comparative efficacy and tolerability of antiemetic prophylaxis for adult highly emetogenic chemotherapy: A network meta-analysis of 143 randomized controlled trials.A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.The Effects of the Bali Yoga Program for Breast Cancer Patients on Chemotherapy-Induced Nausea and Vomiting: Results of a Partially Randomized and Blinded Controlled Trial.Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer.CINV: still troubling patients after all these years.Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-concluding thoughts.Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists.
P2860
Q26744323-519001AA-1560-43BC-94D0-F71C5D055AFBQ30316569-49F1387B-B0D9-4079-8EBD-48D7876D0017Q36093627-578E95E6-8965-45E0-A72E-0184652C9455Q36897218-94EA4FA1-BCAA-4623-AA8D-EBACB097E761Q37735410-1A02ADC8-6D54-4C8F-8678-3C4929B42B63Q38208999-AD0E04CB-6FE0-486D-BC76-CE4ECAD5088BQ38443441-2E7CC4E5-6712-4A86-B8B8-980215423A7AQ38559193-02DC71F3-90FB-404D-B79A-1FFF9B16AA55Q38607350-4940DF9B-8C1D-4246-B2A7-007500D417C7Q38650400-12F49AB6-9D0D-437E-B988-4B848779212DQ39001883-440C719D-D73B-454B-803A-74BAF7EDBB9DQ39027559-F30AA090-9E36-4076-938A-C8F5B47377F2Q42377452-DD36AD5A-6296-4169-BF14-43217B826C72Q46487196-61092474-2733-493D-B4E7-9B98AF351B3CQ47129972-F32D1B66-9035-4519-8241-F0701CC75761Q47549281-ACDCCD43-50D7-4432-8E6D-09E3EAB92B35Q47600642-60C9BF3D-C8AD-4631-815A-F0AB218D8538Q47636194-6296E893-965B-4C08-86D8-CA0DD78B9FACQ48152599-E4136EFA-B0B9-4105-832B-10D31543E6A3Q49570044-8BA3F757-31CC-4E23-9CA5-A2ED7B2A0539Q52805260-9FCB3485-8278-43BE-BD8B-B3355791E8A9Q55010847-983E4760-94ED-49FA-BCD4-4DC2DFB78C7AQ55235442-DEC1A926-A554-4F27-854A-4E4490612C04Q55308113-D753FEE1-D9AC-4E79-8D8F-28436EF5D148Q55381801-D6B695BD-1969-4AE0-8BE3-FCC24C29C68AQ55666180-002B528A-3721-4CE1-AA05-6DF0DB717B2A
P2860
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.
@en
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.
@nl
type
label
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.
@en
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.
@nl
prefLabel
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.
@en
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.
@nl
P2093
P2860
P1476
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.
@en
P2093
Anita R Peoples
Charles Kamen
Gary R Morrow
Karen M Mustian
Michelle C Janelsins
Mohamedtaki A Tejani
P2860
P304
P356
10.1517/14656566.2013.776541
P407
P577
2013-04-01T00:00:00Z